Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Inhibition of UV-Induced Stress Signaling and Inflammatory Responses in SKH-1 Mouse Skin by Topical Small Molecule PD-L1 Blockade

ABSTRACT: The immune checkpoint ligand PD-L1 has emerged as a molecular target for skin cancer therapy and might also hold promise for preventive intervention targeting solar ultraviolet light-induced skin damage. Topical application of the small molecule PD-L1 inhibitor BMS-202 significantly modulates UV-induced inflammation in SKH-1 mouse skin as substantiated by NanoString CounterTM transcriptomic analysis.

ORGANISM(S): Mus musculus

PROVIDER: GSE250046 | GEO | 2023/12/19

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Inhibition of UV-Induced Stress Signaling and Inflammatory Responses in SKH-1 Mouse Skin by Topical Small Molecule PD-L1 Blockade

Project description:Inhibition of UV-Induced Stress Signaling and Inflammatory Responses in SKH-1 Mouse Skin by Topical Small Molecule PD-L1 Blockade

| PRJNA1051651 | ENA

ALPN-202 induces a more potent anti-tumor T cell response in MC38/hPD-L1 tumors than PD-L1 blockade alone

Project description:Purpose: Use RNA-seq to characterize the anti-tumor immune response induced by ALPN-202 and compare to that of anti-PD-L1 treatment alone. Methods: mRNA was isolated from MC38/hPD-L1 tumors 72 hours after a single dose of ALPN-202 (n=4), anti-PD-L1 mAb (durvalumab) (n=4), or Fc control (n=4). Results: ALPN-202 treatment resulted in elevated expression of multiple T cell, NK cell, myeloid cell genes. Additionally, there was a strong increase in genes commonly associated with a proinflammatory response including cytokines, chemokines and surface markers. Conclusions: ALPN-202 treatment resulted in a strong anti-tumor immune response that was more potent than that generated by blockade of PD-L1 alone.

2022-02-10 | GSE161244 | GEO

Mus musculus strain:SKH-1 | breed:SKH-1 Elite hairless

Project description:Mus musculus strain:SKH-1 | breed:SKH-1 Elite hairless Raw sequence reads

| PRJNA564610 | ENA

Mus musculus strain:SKH-1 | breed:SKH-1 Elite hairless

Project description:Mus musculus strain:SKH-1 | breed:SKH-1 Elite hairless Raw sequence reads

| PRJNA564607 | ENA

Mus musculus strain:SKH-1 | breed:SKH-1 Elite hairless

Project description:Mus musculus strain:SKH-1 | breed:SKH-1 Elite hairless Raw sequence reads

| PRJNA564608 | ENA

Mus musculus strain:SKH-1

Project description:Exome-seq for hairless SKH-1 mice skin upon MmuPV1 infection followed by DMBA/UVB.

| PRJNA954057 | ENA

Mus musculus breed:SKH-hairless

Project description:Mus musculus breed:SKH-hairless Exome

| PRJNA352449 | ENA

Acute UV effect on epidermal transcriptome profiling in male and female Wild Type (SKH-1/SV129/BL6/J) mice and deficient for PPARbeta (SKH-1/SV129/BL6/J PPARD-/-) littermates.

Project description:UV irradiation is the most mutagenic and carcinogenic factor identified in non-melanoma skin cancers. Indeed, UV exposure can induce DNA damage in skin cells. However, cells are able to remove these lesions through DNA Damage Response mechanisms, thus avoiding mutagenic DNA lesions. In parallel to this DNA repair pathway induction, cell cycle arrest is induced to allow time to repair or to undergo apoptosis, in this case the UV-induced damage is irreversible. UV exposure has also a mitogenic action by stimulating cell survival and proliferation leading to epidermal hyperplasia. All these intrinsic cellular events induced in response to UV exposure have not been characterized in a sex-dependant context. To explore the key early stages before cancer initiation we performed a single UV exposure experiment. In response to this single UV dose, less severe epidermal atypia was observed in males compared to females.Epidermal transcriptomic data of UV-exposed male and female wild type (SKH-1/SV129/BL6/J)show that in average 12% of genes dysregulated in response to UV are sex-specific. The expression of some transcription factors involved in cell proliferation control are down regulated only in female wild type mice, in response to UV compared to wild type males. Notably, we observed a UV-sex-specific signature in male and female PPARb deficient mice (SKH-1/SV129/BL6/J PPARD KO)suggesting that this nuclear receptor could be involved in the sex-specific response to acute UV exposure. These transcriptomic data obtained in the epidermis from two sexes will help to understand why females are better protected than males from the risk of developing cSCC.

2026-05-20 | GSE266221 | GEO

Mus musculus strain:CD-1 and SKH-1

Project description:Mus musculus strain:CD-1 and SKH-1 Epigenomics

| PRJNA242693 | ENA

Gene-expression profiles of PD-L1-affected CD8+ T cells

Project description:Programmed cell death 1 ligand 1 (PD-L1) is known to suppress immune system and to be an unfavorable prognostic factor in ovarian cancer. The purpose of this study was to elucidate the function of PD-L1 in peritoneal dissemination. Tumor cell lysis by CTLs was attenuated when PD-L1 on tumor cells was overexpressed and promoted when it was silenced. PD-L1 overexpression also inhibited gathering and degranulation of CTLs. Gene expression profile of mouse CTLs caused by PD-L1-overexpressing ovarian cancer was related to human CTLs exhaustion. In mouse ovarian cancer dissemination models, depleting PD-L1 expression on tumor cells resulted in inhibited tumor growth in the peritoneal cavity and prolonged survival. Restoring immune function by inhibiting immune-suppressive factors such as PD-L1 may be a promising therapeutic strategy for peritoneal dissemination. Genome-wide transcriptional changes in OT-1 mouse CD8+ T cells that were co-incubated with OVA peptide-loaded ID8 mouse ovarian cancer cell lines. CTLs from 4 mice were devided into 2 groups, and co-incubated with PD-L1-overexpressed ID8 or PD-L1-depleted ID8.

2012-07-09 | E-GEOD-39205 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data